Magnus Unemo

Magnus Unemo's AcademicInfluence.com Rankings

Magnus Unemo

Philosophy

#5369

World Rank

#8142

Historical Rank

Logic

#2657

World Rank

#3677

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Magnus Unemo's Degrees

Masters Biomedicine Uppsala University

Why Is Magnus Unemo Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Magnus Unemo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting (2015) (1279)
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future (2014) (791)
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016 (2019) (746)
Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone (2011) (602)
High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure (2011) (560)
Sexually transmitted infections: challenges ahead. (2017) (453)
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action (2017) (423)
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults (2013) (386)
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. (2012) (375)
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae (2009) (302)
Whole genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing (2012) (301)
2014 European guideline on the management of syphilis (2014) (300)
Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea. (2016) (275)
Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1 (2008) (246)
Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. (2009) (241)
Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018 (2018) (237)
European guideline for the management of Chlamydia trachomatis infections (2010) (226)
2015 European guideline on the management of Chlamydia trachomatis infections (2010) (224)
Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge (2015) (219)
The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. (2016) (215)
Composition of the Vaginal Microbiota in Women of Reproductive Age – Sensitive and Specific Molecular Diagnosis of Bacterial Vaginosis Is Possible? (2013) (211)
Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. (2010) (205)
Neisseria gonorrhoeae Isolates with Reduced Susceptibility to Cefixime and Ceftriaxone: Association with Genetic Polymorphisms in penA, mtrR, porB1b, and ponA (2007) (192)
Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future (2011) (190)
Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century. (2016) (189)
GONORRHOEA (2019) (177)
Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium (2017) (169)
Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. (2011) (160)
First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. (2011) (149)
Genetics of Chromosomally Mediated Intermediate Resistance to Ceftriaxone and Cefixime in Neisseria gonorrhoeae (2009) (139)
Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey (2018) (139)
Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey (2018) (139)
World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. (2019) (132)
Review and International Recommendation of Methods for Typing Neisseria gonorrhoeae Isolates and Their Implications for Improved Knowledge of Gonococcal Epidemiology, Treatment, and Biology (2011) (131)
Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. (2013) (126)
Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? – a position statement from the European STI Guidelines Editorial Board (2018) (126)
Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus (2013) (124)
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture (2013) (123)
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines (2017) (123)
Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains (2017) (121)
Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. (2010) (120)
New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan (2016) (120)
The Sialic Acid Binding SabA Adhesin of Helicobacter pylori Is Essential for Nonopsonic Activation of Human Neutrophils* (2005) (119)
Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. (2013) (118)
Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014 (2016) (115)
Evaluation of Six Commercial Nucleic Acid Amplification Tests for Detection of Neisseria gonorrhoeae and Other Neisseria Species (2011) (114)
Target Gene Sequencing To Characterize the Penicillin G Susceptibility of Neisseria meningitidis (2007) (110)
Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. (2012) (107)
In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea? (2012) (95)
Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. (2020) (94)
The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization. (2010) (92)
Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden (2010) (90)
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015 (2017) (90)
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015 (2017) (90)
Helicobacter pylori Adapts to Chronic Infection and Gastric Disease via pH-Responsive BabA-Mediated Adherence. (2017) (88)
Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansion (2017) (88)
Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates in Kyoto and Osaka, Japan, 2010 to 2012: Intensified Surveillance after Identification of the First Strain (H041) with High-Level Ceftriaxone Resistance (2013) (86)
2020 European guideline on the management of syphilis (2020) (86)
2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. (2020) (85)
Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for Clostridium difficile Detection Challenges Cytotoxin B Cell Test and Culture as Gold Standard (2010) (83)
Importance of Multidrug Efflux Pumps in the Antimicrobial Resistance Property of Clinical Multidrug-Resistant Isolates of Neisseria gonorrhoeae (2014) (83)
The Swedish new variant of Chlamydia trachomatis (2011) (83)
Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology. (2013) (81)
Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. (2009) (80)
A Novel Mechanism of High-Level, Broad-Spectrum Antibiotic Resistance Caused by a Single Base Pair Change in Neisseria gonorrhoeae (2011) (79)
Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018 (2018) (78)
Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. (2017) (76)
Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. (2018) (76)
2019 European guideline on the management of lymphogranuloma venereum (2019) (75)
Reproductive tract infections including sexually transmitted infections: a population-based study of women of reproductive age in a rural district of Vietnam (2007) (74)
Molecular genetic methods for diagnosis and characterisation of Chlamydia trachomatis and Neisseria gonorrhoeae: impact on epidemiological surveillance and interventions (2004) (74)
WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014. (2016) (74)
Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017 (2017) (74)
Analytical Evaluation of GeneXpert CT/NG, the First Genetic Point-of-Care Assay for Simultaneous Detection of Neisseria gonorrhoeae and Chlamydia trachomatis (2013) (72)
Diagnosing sexually transmitted infections in resource‐constrained settings: challenges and ways forward (2019) (71)
A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene. (2006) (70)
Neisseria gonorrhoeae Strain with High-Level Resistance to Spectinomycin Due to a Novel Resistance Mechanism (Mutated Ribosomal Protein S5) Verified in Norway (2012) (70)
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016 (2018) (70)
An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. (2011) (69)
Population structure of Neisseria gonorrhoeae based on whole genome data and its relationship with antibiotic resistance (2015) (69)
Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin (2015) (68)
High In Vitro Activity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of Gonorrhea (2014) (67)
The impact of antimicrobials on gonococcal evolution (2019) (67)
In Vitro Activity of Ertapenem versus Ceftriaxone against Neisseria gonorrhoeae Isolates with Highly Diverse Ceftriaxone MIC Values and Effects of Ceftriaxone Resistance Determinants: Ertapenem for Treatment of Gonorrhea? (2012) (66)
Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea* (2016) (66)
Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae (2016) (66)
The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe (2019) (65)
In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. (2010) (65)
Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae – the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin (2014) (65)
Molecular Diagnostics for Gonorrhoea: Implications for Antimicrobial Resistance and the Threat of Untreatable Gonorrhoea (2014) (63)
Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea. (2019) (62)
Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. (2006) (59)
Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011 (2013) (59)
In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains (2014) (59)
Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014. (2014) (58)
First Three Neisseria gonorrhoeae Isolates with High-Level Resistance to Azithromycin in Sweden: a Threat to Currently Available Dual-Antimicrobial Regimens for Treatment of Gonorrhea? (2013) (57)
The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health (2012) (57)
Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. (2009) (56)
The European gonococcal antimicrobial surveillance programme, 2009. (2011) (55)
Advancing the public health applications of Chlamydia trachomatis serology. (2018) (55)
Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the Oxford Nanopore MinION sequencer (2018) (55)
Helicobacter pylori adhesion to carbohydrates. (2006) (55)
The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)—a sentinel approach in the European Union (EU)/European Economic Area (EEA) (2013) (54)
The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--national resistance prevalence in 2007 and 2008, and trends during 2005-2008. (2010) (54)
Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan (2015) (54)
Molecular Epidemiology of Neisseria gonorrhoeae: Sequence Analysis of the porB Gene Confirms Presence of Two Circulating Strains (2002) (52)
Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections (2017) (52)
Identification of Amino Acids Conferring High-Level Resistance to Expanded-Spectrum Cephalosporins in the penA Gene from Neisseria gonorrhoeae Strain H041 (2013) (52)
Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use? (2016) (52)
First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China. (2016) (51)
Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse model (2013) (50)
Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae (2017) (50)
In Vitro Activity of Fosfomycin Alone and in Combination with Ceftriaxone or Azithromycin against Clinical Neisseria gonorrhoeae Isolates (2014) (50)
Decreased susceptibility to chlorhexidine and prevalence of disinfectant resistance genes among clinical isolates of Staphylococcus epidermidis (2014) (49)
Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin‐resistant strain (2007) (48)
Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance (2015) (48)
Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics (2015) (47)
Characterization of human invasive isolates of Listeria monocytogenes in Sweden 1986-2007. (2008) (46)
Characterisation of Chlamydia trachomatis by ompA sequencing and multilocus sequence typing in a Swedish county before and after identification of the new variant (2009) (45)
Connector Inversion Probe Technology: A Powerful One-Primer Multiplex DNA Amplification System for Numerous Scientific Applications (2007) (45)
Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae (2015) (45)
Pooling samples: the key to sensitive, specific and cost-effective genetic diagnosis of Chlamydia trachomatis in low-resource countries. (2007) (44)
Antibiotic Susceptibility and Characteristics of Neisseria meningitidis Isolates from the African Meningitis Belt, 2000 to 2006: Phenotypic and Genotypic Perspectives (2009) (44)
Slow Genetic Divergence of Helicobacter pylori Strains during Long-Term Colonization (2005) (43)
High In Vitro Susceptibility to the Novel Spiropyrimidinetrione ETX0914 (AZD0914) among 873 Contemporary Clinical Neisseria gonorrhoeae Isolates from 21 European Countries from 2012 to 2014 (2015) (43)
Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. (2010) (43)
One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure (2002) (42)
Molecular Analyses of TEM Genes and Their Corresponding Penicillinase-Producing Neisseria gonorrhoeae Isolates in Bangkok, Thailand (2011) (42)
Evaluation of the new AmpliSens multiplex real‐time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis (2015) (42)
Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review (2019) (42)
Comparison of Serologic and Genetic porB-Based Typing of Neisseria gonorrhoeae: Consequences for Future Characterization (2003) (42)
Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis. (2019) (41)
Clostridium difficile PCR ribotype 046 is common among neonatal pigs and humans in Sweden. (2014) (41)
Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia (2017) (40)
Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer (2016) (39)
Generating whole bacterial genome sequences of low-abundance species from complex samples with IMS-MDA (2013) (39)
Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae in Europe (2014) (39)
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. (2021) (39)
In Vivo-Selected Compensatory Mutations Restore the Fitness Cost of Mosaic penA Alleles That Confer Ceftriaxone Resistance in Neisseria gonorrhoeae (2018) (39)
Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally (2012) (39)
Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928–2013): antimicrobial use/misuse selects for resistance and drives evolution (2020) (39)
In Vitro Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria gonorrhoeae (2017) (39)
Current and future treatment options for gonorrhoea (2013) (38)
Performance and operational characteristics of point-of-care tests for the diagnosis of urogenital gonococcal infections (2017) (38)
In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae (2018) (38)
First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015–16 (2018) (37)
Antibiotic susceptibility of Propionibacterium acnes isolated from orthopaedic implant-associated infections. (2015) (37)
Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China. (2014) (37)
Analysis of PorA variable region 3 in meningococci: implications for vaccine policy? (2003) (37)
Genome Sequencing of a Neisseria gonorrhoeae Isolate of a Successful International Clone with Decreased Susceptibility and Resistance to Extended-Spectrum Cephalosporins (2012) (36)
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe. (2014) (36)
HIV, STI prevalence and risk behaviours among women selling sex in Lahore, Pakistan (2011) (36)
Total Variation in the penA Gene of Neisseria meningitidis: Correlation between Susceptibility to β-Lactam Antibiotics and penA Gene Heterogeneity (2006) (36)
Alanine 501 Mutations in Penicillin-Binding Protein 2 from Neisseria gonorrhoeae: Structure, Mechanism, and Effects on Cephalosporin Resistance and Biological Fitness. (2017) (36)
Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae (2020) (35)
Novel meningococcal 4CMenB vaccine antigens – prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae (2012) (35)
Rapid accurate point-of-care tests combining diagnostics and antimicrobial resistance prediction for Neisseria gonorrhoeae and Mycoplasma genitalium (2017) (35)
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019 (2020) (35)
Experiences with the new genetic variant of Chlamydia trachomatis in Orebro county, Sweden - proportion, characteristics and effective diagnostic solution in an emergent situation. (2007) (35)
WHO laboratory validation of Xpert® CT/NG and Xpert® TV on the GeneXpert system verifies high performances (2018) (35)
Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone? (2014) (35)
Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates. (2019) (34)
Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014–2016: focus on extended-spectrum cephalosporins and azithromycin (2018) (34)
A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch (2020) (34)
First evaluation of six nucleic acid amplification tests widely used in the diagnosis of Chlamydia trachomatis in Russia (2009) (34)
Mycoplasma genitalium: whole genome sequence analysis, recombination and population structure (2017) (33)
Quantitation of all Four Gardnerella vaginalis Clades Detects Abnormal Vaginal Microbiota Characteristic of Bacterial Vaginosis More Accurately than Putative G. vaginalis Sialidase A Gene Count (2019) (33)
Guidelines for the laboratory diagnosis of trichomoniasis in East European countries (2010) (33)
Multicenter Study for Defining the Breakpoint for Rifampin Resistance in Neisseria meningitidis by rpoB Sequencing (2010) (33)
Resistance to Azithromycin of Neisseria gonorrhoeae Isolates From 2 Cities in China (2011) (33)
Global transmission of prolyliminopeptidase-negative Neisseria gonorrhoeae strains: implications for changes in diagnostic strategies (2006) (33)
The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy. (2012) (32)
Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea. (2015) (32)
Simultaneous species identification and detection of rifampicin resistance in staphylococci by sequencing of the rpoB gene (2009) (32)
Prevalence trends in Sweden for the new variant of Chlamydia trachomatis. (2011) (32)
Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases (2000) (32)
2021 European guideline on the management of Mycoplasma genitalium infections (2022) (32)
Guidelines for the laboratory diagnosis of mycoplasma genitalium infections in East European countries. (2010) (32)
Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union (2013) (32)
Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007–2011 (2013) (32)
Russian gonococcal antimicrobial susceptibility programme (RU-GASP) – resistance in Neisseria gonorrhoeae during 2009–2012 and NG-MAST genotypes in 2011 and 2012 (2014) (31)
Target Gene Sequencing To Define the Susceptibility of Neisseria meningitidis to Ciprofloxacin (2013) (31)
A Novel Factor H–Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae (2012) (31)
Molecular Typing of Neisseria gonorrhoeae Isolates by Pyrosequencing of Highly Polymorphic Segments of the porB Gene (2004) (31)
Innate Recognition by Neutrophil Granulocytes Differs between Neisseria gonorrhoeae Strains Causing Local or Disseminating Infections (2013) (31)
Neisseria gonorrhoeae population in Arkhangelsk, Russia: phenotypic and genotypic heterogeneity. (2007) (31)
Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating penA Sequences in Neisseria gonorrhoeae (2018) (30)
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae. (2014) (30)
Clonally Related Neisseria gonorrhoeae Isolates with Decreased Susceptibility to the Extended-Spectrum Cephalosporin Cefotaxime in Amsterdam, the Netherlands (2012) (30)
Background review for the '2015 European guideline on the management of Chlamydia trachomatis infections'. (2015) (30)
Recent trends in gonorrhoea and syphilis epidemiology in Sweden: 2007 to 2011. (2012) (30)
Challenges with gonorrhea in the era of multi-drug and extensively drug resistance – are we on the right track? (2014) (29)
Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010–2013 (2015) (29)
A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae (2017) (29)
The porA pseudogene of Neisseria gonorrhoeae– low level of genetic polymorphism and a few, mainly identical, inactivating mutations (2005) (28)
Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16. (2019) (28)
Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infections (2020) (27)
In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains (2018) (27)
Clinical Validation of a Real-Time Polymerase Chain Reaction Detection of Neisseria gonorrheae porA Pseudogene Versus Culture Techniques (2008) (27)
First evaluation of polymerase chain reaction assays used for diagnosis of Mycoplasma genitalium in Russia (2009) (26)
Test of Cure for Anogenital Gonorrhoea Using Modern RNA-Based and DNA-Based Nucleic Acid Amplification Tests: A Prospective Cohort Study. (2016) (26)
Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial (2010) (26)
High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa (2010) (26)
Pharmacokinetic Data Are Predictive of In Vivo Efficacy for Cefixime and Ceftriaxone against Susceptible and Resistant Neisseria gonorrhoeae Strains in the Gonorrhea Mouse Model (2019) (26)
Multiplex Real-Time PCR Assay with High-Resolution Melting Analysis for Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae (2016) (26)
Mutations in fusA Associated with Posttherapy Fusidic Acid Resistance in Clostridium difficile (2007) (25)
Guidelines for the laboratory diagnosis of syphilis in East European countries (2009) (25)
Increase in reported gonorrhoea cases in Sweden, 2001 - 2008. (2009) (25)
National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005–2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia (2008) (25)
Molecular epidemiology of Neisseria gonorrhoeae– identification of the first presumed Swedish transmission chain of an azithromycin‐resistant strain (2006) (24)
Dual antimicrobial therapy for gonorrhoea: what is the role of azithromycin? (2018) (24)
Global phylogeny of Treponema pallidum lineages reveals recent expansion and spread of contemporary syphilis (2021) (24)
Detailed characterization of the first high-level azithromycin-resistant Neisseria gonorrhoeae cases in Ireland. (2015) (24)
Genome-Based Characterization of Emergent Invasive Neisseria meningitidis Serogroup Y Isolates in Sweden from 1995 to 2012 (2015) (24)
Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia (2020) (24)
Mismatch Amplification Mutation Assay-Based Real-Time PCR for Rapid Detection of Neisseria gonorrhoeae and Antimicrobial Resistance Determinants in Clinical Specimens (2018) (23)
Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing. (2005) (23)
Time to clearance of Chlamydia trachomatis RNA and DNA after treatment in patients coinfected with Neisseria gonorrhoeae – a prospective cohort study (2016) (23)
Successful Combination of Nucleic Acid Amplification Test Diagnostics and Targeted Deferred Neisseria gonorrhoeae Culture (2015) (23)
Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011–2015 (2018) (23)
The Swedish new variant of Chlamydia trachomatis (nvCT) remains undetected by many European laboratories as revealed in the recent PCR/NAT ring trial organised by INSTAND e.V., Germany. (2009) (23)
Laboratory diagnosis of Neisseria gonorrhoeae in St Petersburg, Russia: inventory, performance characteristics and recommended optimisations (2006) (23)
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area (2019) (22)
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018. (2021) (22)
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area (2019) (22)
Syphilis epidemiology in 1994–2013, molecular epidemiological strain typing and determination of macrolide resistance in Treponema pallidum in 2013–2014 in Tuva Republic, Russia (2016) (22)
Pulsed-Field Gel Electrophoresis as an Epidemiologic Tool for Neisseria gonorrhoeae: Identification of Clusters Within Serovars (2002) (22)
Antibiotic susceptibility in prostate‐derived Propionibacterium acnes isolates (2012) (22)
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018. (2021) (22)
Can the Swedish new variant of Chlamydia trachomatis (nvCT) be detected by UK NEQAS participants from seventeen European countries and five additional countries/regions in 2009? (2009) (21)
2014 European guideline on the management of syphilis: giving evidence priority (2016) (21)
Genomic Characterization of Urethritis-Associated Neisseria meningitidis Shows that a Wide Range of N. meningitidis Strains Can Cause Urethritis (2017) (21)
Initial impacts of the COVID-19 pandemic on sexual and reproductive health service use and unmet need in Britain: findings from a quasi-representative survey (Natsal-COVID) (2022) (21)
PCR of Cerebrospinal Fluid for Diagnosis of Bacterial Meningitis During Meningococcal Epidemics; an Example from Sudan (2003) (21)
Propionibacterium acnes as an etiological agent of arthroplastic and osteosynthetic infections--two cases with specific clinical presentation including formation of draining fistulae. (2010) (21)
Five-day Azithromycin Treatment Regimen for Mycoplasma genitalium Infection Also Effectively Eradicates Chlamydia trachomatis. (2015) (21)
Clinical Neisseria gonorrhoeae isolate with a N. meningitidis porA gene and no prolyliminopeptidase activity, Sweden, 2011: danger of false-negative genetic and culture diagnostic results. (2012) (21)
Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines (2012) (21)
Prevalence and Molecular Epidemiological Typing of Penicillinase-Producing Neisseria gonorrhoeae and Their blaTEM-135 Gene Variants in Nanjing, China (2013) (21)
Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer (2016) (21)
Analytical specificity and sensitivity of the APTIMA Combo 2 and APTIMA GC assays for detection of commensal Neisseria species and Neisseria gonorrhoeae on the Gen-Probe Panther instrument. (2013) (20)
Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16. (2020) (20)
Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction. (2020) (20)
Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015–16 (2020) (20)
Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report (2014) (20)
Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012 (2014) (19)
The Neisseria gonorrhoeae population in Sweden during 2005—phenotypes, genotypes and antibiotic resistance (2008) (19)
Background review for the ‘2020 European guideline for the diagnosis and treatment of gonorrhoea in adults’ (2020) (19)
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013–2018 (2019) (19)
Appropriate time for test-of-cure when diagnosing gonorrhoea with a nucleic acid amplification test. (2012) (19)
Guidelines for the laboratory diagnosis of genital herpes in eastern European countries. (2010) (19)
Poverty of Opportunity Forcing Women Into Prostitution—A Qualitative Study in Pakistan (2010) (19)
Knowledge, attitudes and practices regarding human immunodeficiency virus/acquired immune deficiency syndrome and sexually transmitted infections among health care providers in Lahore, Pakistan. (2009) (19)
Guidelines for the laboratory diagnosis of Chlamydia trachomatis infections in East European countries (2009) (18)
Evaluation of six nucleic acid amplification tests used for diagnosis of Neisseria gonorrhoeae in Russia compared with an international strictly validated real‐time porA pseudogene polymerase chain reaction (2009) (18)
Real‐time PCR and subsequent pyrosequencing for screening of penA mosaic alleles and prediction of reduced susceptibility to expanded‐spectrum cephalosporins in Neisseria gonorrhoeae (2008) (18)
Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial. (2020) (18)
Genetic homogeneity/heterogeneity of Propionibacterium acnes isolated from patients during cardiothoracic reoperation. (2007) (18)
Population‐based assessment of Mycoplasma genitalium in Vietnam – low prevalence among married women of reproductive age in a rural area (2009) (18)
Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants* (2018) (18)
Evaluation of the new COBAS TaqMan CT test v2.0 and impact on the proportion of new variant Chlamydia trachomatis by the introduction of diagnostics detecting new variant C trachomatis in Örebro county, Sweden (2008) (17)
In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains. (2015) (17)
The Finnish New Variant of Chlamydia trachomatis with a Single Nucleotide Polymorphism in the 23S rRNA Target Escapes Detection by the Aptima Combo 2 Test (2019) (17)
Laboratory diagnostics for non‐viral sexually transmitted infections in St. Petersburg, Russia: current situation and hallmarks for improvements (2008) (17)
Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance With World Health Organization Standards, in Côte d'Ivoire, Western Africa, 2014–2017 (2019) (17)
Multilocus sequence typing and repetitive-sequence-based PCR (DiversiLab) for molecular epidemiological characterization of Propionibacterium acnes isolates of heterogeneous origin. (2012) (17)
Analytical evaluation of nine serological assays for diagnosis of syphilis (2015) (17)
Guidelines for laboratory diagnosis of Neisseria gonorrhoeae infections in Eastern European countries--results of an international collaboration. (2007) (16)
Laboratory Diagnosis of Sexually Transmitted Infections in Estonia in 2001–2002: Shortcomings With Impact on Diagnostic Quality and Surveillance (2005) (16)
Genetic diversity of blaTEM alleles, antimicrobial susceptibility and molecular epidemiological characteristics of penicillinase-producing Neisseria gonorrhoeae from England and Wales. (2015) (16)
Comparison of microscopy, culture and in‐house PCR and NASBA assays for diagnosis of Neisseria gonorrhoeae in Russia (2008) (16)
Neisseria meningitidis serogroup W-135 isolated from healthy carriers and patients in Sudan after the Hajj in 2000. (2003) (16)
High in vitro activity of a novel dual bacterial topoisomerase inhibitor of the ATPase activities of GyrB and ParE (VT12-008911) against Neisseria gonorrhoeae isolates with various high-level antimicrobial resistance and multidrug resistance. (2014) (16)
Diagnosis of Chlamydia trachomatis in Russia – in‐house PCR assays may be effective but overall optimization and quality assurance are urgently needed (2006) (15)
Evaluation of polymerase chain reaction assays for the diagnosis of Trichomonas vaginalis infection in Russia (2013) (15)
Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae in a Dynamic Hollow Fiber Infection Model (2021) (15)
Antimicrobial resistance in Mycoplasma genitalium sampled from the British general population (2020) (15)
Finnish new variant of Chlamydia trachomatis escaping detection in the Aptima Combo 2 assay also present in Örebro County, Sweden, May 2019 (2019) (15)
Gentamicin in vitro activity and tentative gentamicin interpretation criteria for the CLSI and calibrated dichotomous sensitivity disc diffusion methods for Neisseria gonorrhoeae. (2016) (15)
In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae. (2019) (15)
Pyrosequencing of the DNA gyrase gene in Neisseria species: effective indicator of ciprofloxacin resistance in Neisseria gonorrhoeae (2006) (15)
Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae (2018) (14)
Evaluation and subsequent optimizations of the quantitative AmpliSens Florocenosis/Bacterial vaginosis‐FRT multiplex real‐time PCR assay for diagnosis of bacterial vaginosis (2016) (14)
Distribution of Chlamydia trachomatis ompA genovars and the new variant of C. trachomatis in the Göteborg area, Sweden (2010) (14)
Antimicrobial susceptibility in Neisseria gonorrhoeae isolates from five sentinel surveillance sites in Zimbabwe, 2015–2016 (2017) (14)
Gonorrhoea surveillance, laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae in 11 countries of the eastern part of the WHO European region (2011) (14)
High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA‐approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine (2019) (14)
Molecular characterisation of group A Neisseria meningitidis isolated in Sudan 1985–2001 (2003) (14)
The new variant of Chlamydia trachomatis was present as early as 2003 in Örebro County, Sweden, but remained undetected until 2006 (2013) (14)
Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data (2019) (13)
In vitro activity and time‐kill curve analysis of sitafloxacin against a global panel of antimicrobial‐resistant and multidrug‐resistant Neisseria gonorrhoeae isolates (2018) (13)
Ten years transmission of the new variant of Chlamydia trachomatis in Sweden: prevalence of infections and associated complications (2017) (13)
Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015 (2019) (13)
Transformation of ciprofloxacin-resistant Neisseria gonorrhoeae gyrA, parE and porB1b genes. (2006) (13)
Future treatment of gonorrhoea – novel emerging drugs are essential and in progress? (2015) (13)
Quality enhancements and quality assurance of laboratory diagnosis of sexually transmitted infections in Eastern Europe (2009) (13)
Evaluation of the rapid loop‐mediated isothermal amplification assay Illumigene for diagnosis of Clostridium difficile in an outbreak situation (2014) (13)
Adherence to the 2012 European gonorrhoea guideline in the WHO European Region according to the 2018–19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group gonorrhoea survey (2019) (13)
Phenotypic and genetic characterisation of bacterial sexually transmitted infections in Bissau, Guinea-Bissau, West Africa: a prospective cohort study (2012) (13)
Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study. (2022) (13)
Efflux Pumps in Neisseria gonorrhoeae: Contributions to Antimicrobial Resistance and Virulence (2016) (13)
Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012–2014 in Karachi, Pakistan (2016) (13)
C4BP-IgM protein as a novel therapeutic approach to treat Neisseria gonorrhoeae infections. (2019) (13)
Letter to the editor: Chlamydia trachomatis samples testing falsely negative in the Aptima Combo 2 test in Finland, 2019 (2019) (13)
Sexual behaviours, knowledge and attitudes regarding safe sex, and prevalence of non‐viral sexually transmitted infections among attendees of youth clinics in St. Petersburg, Russia (2013) (13)
Antibiotic susceptibility of Neisseriagonorrhoeae in Arkhangelsk, Russia (2006) (13)
Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus (2020) (13)
Staphylococcal cassette chromosome mec (SCCmec) and arginine catabolic mobile element (ACME) in Staphylococcus epidermidis isolated from prosthetic joint infections (2013) (13)
Aptima Trichomonas vaginalis assay elucidates significant underdiagnosis of trichomoniasis among women in Brazil according to an observational study (2018) (12)
In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates. (2018) (12)
Home sampling and pooling of vaginal samples are effective tools for genetic screening of Chlamydia trachomatis among high school female students in Lithuania (2008) (12)
The ‘Finnish new variant of Chlamydia trachomatis’ escaping detection in the Aptima Combo 2 assay is widespread across Norway, June to August 2019 (2019) (12)
Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea - challenges and opportunities. (2020) (12)
Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012–2017 (2019) (12)
Prevalence, Macrolide Resistance, and Fluoroquinolone Resistance in Mycoplasma genitalium in Men Who Have Sex With Men Attending an Sexually Transmitted Disease Clinic in Dublin, Ireland in 2017–2018 (2019) (12)
Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae. (2020) (12)
Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae. (2020) (12)
Genetic variation regulates the activation and specificity of Restriction-Modification systems in Neisseria gonorrhoeae (2019) (12)
Mutations in penicillin-binding protein 2 from cephalosporin-resistant Neisseria gonorrhoeae hinder ceftriaxone acylation by restricting protein dynamics (2020) (12)
In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea? (2019) (12)
Trichomonas vaginalis infections are rare among young patients attending an STI clinic in Sweden. (2015) (11)
Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions. (2021) (11)
A Premature Infant with Fulminant Meningococcal Septicaemia (2003) (11)
Antibiotic resistance and NG-MAST sequence types of Neisseria gonorrhoeae isolates in Poland compared to the world (2018) (11)
Pathogenic Interplay Between Chlamydia trachomatis and Neisseria gonorrhoeae that Influences Management and Control Efforts—More Questions than Answers? (2019) (11)
Phenotypic and genotypic characterization of prolyliminopeptidase-negative Neisseria gonorrhoeae isolates in Denmark (2005) (11)
Mitigating the emergence and spread of multidrug- and extensively drug-resistant gonorrhea: is there sufficient support in resource-poor settings in Africa? (2014) (10)
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients’ gender, sexual orientation and anatomical site of infection, 2009–2016 (2021) (10)
Molecular typing of Neisseria gonorrhoeae – a study of 2013 isolates (2018) (10)
Evaluation of Neisseria gonorrhoeae Multiple-Locus Variable-Number Tandem-Repeat Analysis, N. gonorrhoeae Multiantigen Sequence Typing, and Full-Length porB Gene Sequence Analysis for Molecular Epidemiological Typing (2011) (10)
Impact of screening on the prevalence and incidence of Mycoplasma genitalium and its macrolide resistance in men who have sex with men living in Australia: A mathematical model (2021) (10)
Diagnosis of non-viral sexually transmitted infections in Lithuania and international recommendations. (2006) (10)
First reported case of the Swedish new variant of Chlamydia trachomatis (nvCT) in Eastern Europe (Russia), and evaluation of Russian nucleic acid amplification tests regarding their ability to detect nvCT. (2012) (10)
Phenotypic and genotypic characterization of prolyliminopeptidase-negative Neisseria gonorrhoeae isolates in Denmark (2005) (10)
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients’ gender, sexual orientation and anatomical site of infection, 2009–2016 (2021) (10)
Infection: Proof of principle for effectiveness of a gonorrhoea vaccine (2017) (10)
In vitro antimicrobial synergy testing of coagulase-negative staphylococci isolated from prosthetic joint infections using Etest and with a focus on rifampicin and linezolid (2010) (10)
Combined Real-Time PCR and Pyrosequencing Strategy for Objective, Sensitive, Specific, and High-Throughput Identification of Reduced Susceptibility to Penicillins in Neisseria meningitidis (2007) (10)
Pooling of urine specimens allows accurate and cost-effective genetic detection of Chlamydia trachomatis in Lithuania and other low-resource countries (2007) (10)
Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants (2020) (10)
Increased antibiotic susceptibility in Neisseria gonorrhoeae through adaptation to the cervical environment (2020) (10)
Genotypic and Phenotypic Stability of Helicobacter pylori Markers in a Nine-Year Follow-up Study of Patients with Noneradicated Infection (2005) (10)
Genomic epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates from Ukraine, 2013–2018 (2020) (10)
In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium (2020) (10)
A community-driven resource for genomic surveillance of Neisseria gonorrhoeae at Pathogenwatch (2020) (9)
Antibiotic susceptibility of invasive Neisseria meningitidis isolates from 1995 to 2008 in Sweden—the meningococcal population remains susceptible (2010) (9)
The first wide‐scale drug repurposing screen using the Prestwick Chemical Library (1200 bioactive molecules) against Neisseria gonorrhoeae identifies high in vitro activity of auranofin and many additional drugs (2019) (9)
Diagnostics, surveillance and management of sexually transmitted infections in Europe have to be improved: lessons from the European Conference of National Strategies for Chlamydia Trachomatis and Human Papillomavirus (NSCP conference) in Latvia, 2011 (2012) (9)
Significant increase in azithromycin “resistance” and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019 (2022) (9)
Targeting the tcdA Gene: Is This Appropriate for Detection of A and/or B Clostridium difficile Toxin-Producing Strains? (2011) (9)
Significant increase in azithromycin “resistance” and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019 (2022) (9)
Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022 (2022) (9)
Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, Uganda (2020) (9)
Antimicrobial susceptibility/resistance and molecular epidemiological characteristics of Neisseria gonorrhoeae in 2009 in Belarus (2011) (9)
Prospects of untreatable gonorrhea and ways forward. (2015) (8)
Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute disc diffusion techniques (2016) (8)
Gonorrhoea treatment combined with population-level general cephalosporin and quinolone consumption may select for Neisseria gonorrhoeae antimicrobial resistance at the levels of NG-MAST genogroup: an ecological study in Europe. (2020) (8)
Gonorrhoea: a systematic review of prevalence reporting globally (2021) (8)
Most but not all laboratories can detect the recently emerged Neisseria gonorrhoeae porA mutants - results from the QCMD 2013 N. gonorrhoeae external quality assessment programme. (2014) (8)
Prediction of Minimum Inhibitory Concentrations of Antimicrobials for Neisseria gonorrhoeae Using Whole-Genome Sequencing. (2019) (8)
The evolution of infectious agents in relation to sex in animals and humans: brief discussions of some individual organisms (2011) (8)
Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model (2022) (8)
Intimate physical contact between people from different households during the COVID-19 pandemic: a mixed-methods study from a large, quasi-representative survey (Natsal-COVID) (2021) (7)
Genomic and phenotypic characterisation of invasive neonatal and colonising group B Streptococcus isolates from Slovenia, 2001–2018 (2020) (7)
Antimicrobial resistance in Neisseria gonorrhoeae isolates from foreign-born population in the European Gonococcal Antimicrobial Surveillance Programme (2020) (7)
P1.020 Phenotypic and Genetic Characterization of the First Three Cases of Extended-Spectrum Cephalosporin Resistant Neisseria Gonorrhoeae Infection in South Africa and Association with Cefixime Treatment Failure (2013) (7)
Antimicrobial exposure in sexual networks drives divergent evolution in modern gonococci (2018) (7)
Antimicrobial resistance prediction in Neisseria gonorrhoeae: current status and future prospects (2021) (7)
Neisseria: Molecular Mechanisms of Pathogenesis (2010) (7)
Absence of Swedish new variant Chlamydia trachomatis (nvCT) and C. trachomatis genotype distribution in Gipuzkoa, Spain, 2009-2010. (2012) (7)
Challenges with antimicrobial susceptibility testing for Neisseria gonorrhoeae in the era of extensively drug-resistant gonorrhoea — molecular antimicrobial resistance testing crucial (2014) (7)
Evaluation of the New BD Max GC Real-Time PCR Assay, Analytically and Clinically as a Supplementary Test for the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Detection of Neisseria gonorrhoeae (2015) (7)
Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants. (2019) (7)
Phylogenomics for drug-resistant Neisseria gonorrhoeae. (2014) (7)
Fitness cost and benefit of antimicrobial resistance in Neisseria gonorrhoeae: Multidisciplinary approaches are needed (2017) (6)
High In Vitro Susceptibility to the First-in-Class Spiropyrimidinetrione Zoliflodacin among Consecutive Clinical Neisseria gonorrhoeae Isolates from Thailand and South Africa (2019) (6)
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults C Bignell MBBS FRCP*, M Unemo PhD † on behalf of the European STI Guidelines Editorial Board (2014) (6)
Time-kill curve analysis and pharmacodynamic functions for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae (2015) (6)
Prevalence of Mycoplasma genitalium and Antibiotic Resistance-Associated Mutations in Patients at a Sexually Transmitted Infection Clinic in Iceland, and Comparison of the S-DiaMGTV and Aptima Mycoplasma genitalium Assays for Diagnosis (2020) (6)
Emergence of the new variant of Chlamydia trachomatis in a defined area of Sweden before 2002? (2010) (6)
Accurate, rapid, point-of-care tests for sexually transmitted infections. (2020) (6)
Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen (2016) (6)
3 – Infections Caused by Chlamydia Trachomatis (2010) (6)
Gonorrhoea in 21st century--international and Polish situation. (2014) (6)
Rise and fall of the new variant of Chlamydia trachomatis in Sweden: mathematical modelling study (2019) (6)
The Sequencing Bead Array (SBA), a Next-Generation Digital Suspension Array (2013) (6)
The 2018–19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group report on the diagnosis and treatment of gonorrhoea in Europe (2019) (6)
C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections (2019) (6)
Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009–2019 (2020) (6)
Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018. (2022) (5)
Syphilis in females in Bialystok, Poland, 2000-2015 (2016) (5)
Gonococcal Osteomyelitis Resulting in Permanent Sequelae. (2016) (5)
Prevalence and risk factors associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium among women in Pelotas, Southern Brazil (2020) (5)
A profile of the FDA-approved and CE/IVD-marked Aptima Mycoplasma genitalium assay (Hologic) and key priorities in the management of M. genitalium infections (2020) (5)
Erratum to: Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer (2016) (5)
First antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia, 2009–2013 (2014) (5)
Clinical Importance of Superior Sensitivity of the Aptima TMA-Based Assays for Mycoplasma genitalium Detection (2022) (5)
Contemporary syphilis is characterised by rapid global spread of pandemic Treponema pallidum lineages (2021) (5)
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates in Yaoundé, Cameroon From 2009 to 2014. (2018) (5)
Trichomonas vaginalis is Rare Among Women in Iceland. (2017) (5)
Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended‐spectrum cephalosporins for public health purposes (2011) (5)
Does the ‘2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe’ depict the situation in Europe? (2013) (5)
Clinical and epidemiological characteristics of males with syphilis in Białystok, Poland in 2008-2013. (2015) (4)
Prevalence Trends of the New Variant of Chlamydia trachomatis in Four Counties of Sweden in 2007–2011 (2012) (4)
Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017 (2021) (4)
A Chlamydia trachomatis 23S rRNA G1523A variant escaping detection in the Aptima Combo 2 assay (Hologic) was widespread across Denmark in July–September 2019 (2020) (4)
P05.09 Phenotypic, genetic and genomic characterisation of the 2015 who neisseria gonorrhoeae reference strains for quality assurance of laboratory investigations globally (2015) (4)
O03.1 Risk Factors For Antimicrobial Resistant Neisseria Gonorrhoeae in Europe (2013) (4)
Role of Molecular Biology in Diagnosis and Characterization of Vulvo-Vaginitis in Clinical Practice (2017) (4)
GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility. (2022) (4)
Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi (2021) (4)
Changes in testing and incidence of Chlamydia trachomatis and Neisseria gonorrhoeae – the possible impact of the COVID-19 pandemic in the three Scandinavian countries (2022) (4)
P2.087 In Vitro Antimicrobial Synergy Testing, Using Etest Methodology, of Neisseria Gonorrhoeae For Evaluation of Susceptibility When Using Dual Antimicrobial Therapy? (2013) (4)
Validation of an Aptima-format Finnish new variant of Chlamydia trachomatis (FI-nvCT) surveillance assay, 2019 (2020) (4)
Trichomonas vaginalis is very rare among women with vaginal discharge in Podlaskie province, Poland (2017) (4)
Potential impact of the COVID‐19 pandemic on the national and regional incidence, epidemiology and diagnostic testing of chlamydia and gonorrhoea in Sweden, 2020 (2021) (4)
Evaluation of three serological tests manufactured in Belarus for the diagnosis of syphilis. (2011) (3)
The 2014 European guideline on the management of syphilis has now been published. (2014) (3)
Neisseria gonorrhoeae 2005 Annual report regarding serological characterisation and antibiotic susceptibility of Swedish Neisseria gonorrhoeae strains (2006) (3)
Prevalence, phenotypic and genetic characteristics of prolyliminopeptidase‐negative Neisseria gonorrhoeae isolates in Sweden during 2000–2007 (2009) (3)
Collecting and exploiting data to understand a nation’s sexual health needs: Implications for the British National Surveys of Sexual Attitudes and Lifestyles (Natsal) (2018) (3)
Health-seeking behaviour of women selling sex in Lahore, Pakistan (2011) (3)
Lack of diagnostic-escape mutants of Group B Streptococcus in Slovenia. (2021) (3)
Lymphogranuloma venereum (LGV) in men who have sex with men (MSM): a re-emerging problem, Malta, 2018 (2018) (3)
Laboratory support for the diagnosis and surveillance of sexually transmitted infections (STIs) in Eastern Europe. (2009) (3)
The European response to control and manage multi- and extensively drug-resistant Neisseria gonorrhoeae (2022) (3)
Neisseria gonorrhoeae Is Evolving into a ‘Superbug’ – what Measures Can Be Implemented to Combat the Emergence of Multidrug and Extensively-drug Resistant Gonorrhoea in Latin America and Globally? (2013) (3)
Reply to “Routine Confirmation of Positive Nucleic Acid Amplification Test Results for Neisseria gonorrhoeae Is Not Necessary” (2012) (3)
P601 Macrolide and fluoroquinolone resistance-associated mutations in mycoplasma genitalium: a systematic review and meta-analysis (2019) (3)
Laboratory diagnosis of sexually transmitted infections in Belarus. (2011) (3)
First National Genomic Epidemiological Study of Neisseria gonorrhoeae Strains Spreading Across Sweden in 2016 (2022) (3)
EVOLUTION OF INFECTIOUS AGENTS IN RELATION TO SEX (2011) (3)
Gonococcal Clinical Strains Bearing a Common gdhR Single Nucleotide Polymorphism That Results in Enhanced Expression of the Virulence Gene lctP Frequently Possess a mtrR Promoter Mutation That Decreases Antibiotic Susceptibility (2022) (3)
High in vitro activity of DIS-73285, a novel antimicrobial with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae (2020) (3)
How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID) (2022) (3)
Molecular epidemiological typing of Neisseria gonorrhoeae isolates identifies a novel association between genogroup G10557 (G7072) and decreased susceptibility to cefixime, Germany, 2014 to 2017 (2020) (3)
Sexual and Reproductive Health in Britain During the First Year of the COVID-19 Pandemic: National Population Survey (Natsal-COVID Study) (2022) (2)
Performance of the first commercial dual resistance assay, AmpliSens Mycoplasma genitalium-ML/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of M. genitalium resistance mutations in St. Petersburg, Russia (2022) (2)
Analytical specificity and sensitivity of the novel dual‐target GeneProof Neisseria gonorrhoeae PCR kit for detection of N. gonorrhoeae (2015) (2)
Lymphogranuloma venereum genovar L2b concomitantly with syphilis and hepatitis C in a male patient in Poland – case report (2018) (2)
Will Genome Analysis Elucidate Evolution, Global Transmission and Virulence of Neisseria Meningitidis Lineages? (2015) (2)
Lymphogranuloma venereum: an emerging problem in Poland (2020) (2)
P2.022 Laboratory Diagnosis of Genital Neisseria Gonorrhoeae Infections in Three Regions of Ukraine (2013) (2)
Re-emergence of domestic gonorrhoea in Sweden. (2001) (2)
Survey of diagnostic services for genital herpes in fourteen countries in Eastern Europe. (2011) (2)
O21.3 Fitness Studies on Neisseria Gonorrhoeae Harboring Mosaic penA Alleles from Ceftriaxone-Resistant Isolates Predict the Spread of Resistance to Extended-Spectrum Cephalosporins (2013) (2)
Genotypic and phenotypic characterisation of Neisseria gonorrhoeae (2003) (2)
Quantitative proteomics of the 2016 WHO Neisseria gonorrhoeae reference strains surveys vaccine candidates and antimicrobial resistance determinants (2018) (2)
First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020 (2021) (2)
Spread of the new variant of Chlamydia trachomatis within Sweden over time (2012) (2)
Technologies, strategies and approaches for testing populations at risk of sexually transmitted infections: a systematic review protocol to inform prevention and control in EU/EEA countries (2020) (2)
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018–19 (2021) (2)
National surveillance of Neisseria gonorrhoeae antimicrobial susceptibility and epidemiological data of gonorrhoea patients across Brazil, 2018–20 (2022) (2)
No widespread dissemination of Chlamydia trachomatis diagnostic-escape variants and the impact of Neisseria gonorrhoeae positivity on the Aptima Combo 2 assay (2021) (2)
P3.157 Does the european gonococcal antimicrobial surveillance programme (EURO-GASP) accurately reflect the true antimicrobial resistance situation in europe? (2017) (2)
PL01.1 Antimicrobial Resistance in Neisseria Gonorrhoeae and Possible Emergence of Untreatable Gonorrhoea: How, When and Essential Actions? (2013) (2)
P2.046 Evaluation of Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF-MS) For Species Identification Within the Neisseria Genus - Effective Alternative to Conventional Techniques? (2013) (2)
P2.021 Prevalence of Sexually Transmitted Infections in Young People in St. Petersburg, Russia, as Determined Using Self-Collected Non-Invasive Specimens (2013) (2)
Initial Impacts of COVID-19 on Sexual and Reproductive Health Service Use and Unmet Need in Britain: Findings from a Large, Quasi-Representative Survey (Natsal-COVID) (2021) (2)
Reply to “Management of Pharyngeal Gonorrhea Is Crucial To Prevent the Emergence and Spread of Antibiotic-Resistant Neisseria gonorrhoeae” (2012) (2)
P5.077 Nucleic Acid Amplification Test (NAAT) Diagnostics Combined with Delayed Neisseria Gonorrhoeae Cultivation of NAAT Positive Samples Using the ESwab™ System - the Solution For Future Gonococcal Antimicrobial Susceptibility Surveillance? (2013) (2)
Is the end of gonorrhoea in sight? (2022) (2)
Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019 (2021) (1)
Prevalence, phenotypic and genotypic characterisation of Neisseria meningitidis comprising reduced susceptibility or resistance to rifampicin and/or ciprofloxacin in Sweden (2008) (1)
Second European Multi-Disciplinary Conference of National Strategies for Chlamydia Trachomatis and Human Papillomavirus (NSCP Conference) in Berlin, 2013 — Enhanced Detection, Management and Surveillance of Sexually Transmitted Infections in Europe are Essential! (2013) (1)
LB1.61 Prevalence of trichomonas vaginalis among women attending a university clinic in pelotas, brazil using microscopy, culture and the aptima tv assay (2017) (1)
In vitro activity of the ketolide cethromycin in multidrug-resistant clinical Neisseria gonorrhoeae isolates and international reference strains (2019) (1)
P2.30 Survey of antimicrobial resistance in clinical neisseria gonorrhoeae isolated over a period of four years in nairobi – kenya (2017) (1)
Optimizations to keep gonorrhoea treatable and reduce antimicrobial resistance selection (2020) (1)
Serum Complement Activation by C4BP-IgM Fusion Protein Can Restore Susceptibility to Antibiotics in Neisseria gonorrhoeae (2021) (1)
P3.288 Antimicrobial Susceptibility and Molecular Epidemiologic Clusters of Neisseria Gonorrhoeae Strains in 2007 and 2012 in Nanjing, China (2013) (1)
First reported lymphogranuloma venereum cases in Russia discovered in men who have sex with men attending proctologists (2022) (1)
P3.032 Epidemiology of Sexually Transmitted Infections in Tver, Russia (2013) (1)
Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections (2022) (1)
Comparison of gastrointestinal side effects from different doses of azithromycin for the treatment of gonorrhoea (2022) (1)
Oxford Nanopore MinION genome sequencer: performance characteristics, optimised analysis workflow, phylogenetic analysis and prediction of antimicrobial resistance in Neisseria gonorrhoeae (2018) (1)
O3-S4.01 The new superbug Neisseria gonorrhoeae makes gonorrhoea untreatable?—first high-level ceftriaxone resistance worldwide and public health importance (2011) (1)
Now Is the Time to Implement Whole Genome Sequencing in the Global Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae? (2019) (1)
Impact on the proportion of the new variant of Chlamydia trachomatis (nvCT) by introduction of diagnostics detecting nvCT and evaluation of Cobas TaqMan48 CT Test v2.0 for C. trachomatis diagnostics in Örebro county, Sweden (2008) (1)
005.3 Multiplex real-time pcr with high resolution melting analysis for detecting resistance mechanisms in neisseria gonorrhoeae (2015) (1)
Potent In Vitro and Ex Vivo Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin A (2022) (1)
First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017–2020 (2022) (1)
Mutations in penicillin-binding protein 2 from cephalosporin-resistant Neisseria gonorrhoeae hinder ceftriaxone acylation by restricting protein dynamics. (2020) (1)
The '2015 European guideline on the management of Chlamydia trachomatis infections' has now been published. (2015) (1)
Clostridium difficile PCR ribotype 027 / PFGE type NAP 1 – why is it emerging ? (2008) (1)
LBP-1.04 International validation of AmpliSens NAAT systems manufactured in Russia for diagnosis of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis (2011) (1)
O03.2 Antimicrobial Resistance of Neisseria Gonorrhoeae in the European Union: Response to the Threat of Multidrug Resistant Gonorrhoea (2013) (1)
S15.2 European gonococcal antimicrobial surveillance programme (Euro-GASP): towards timelier monitoring (2011) (1)
Evolutionary epidemiology of Neisseria meningitidis strains in Belarus compared to other European countries. (2013) (1)
O01.8 Contemporary syphilis is characterised by rapid global spread of pandemic Treponema pallidum lineages (2021) (1)
Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022 (2022) (1)
P673 In-vitro activity of SMT-571 and comparators against clinical isolates and reference strains of neisseria gonorrhoeae (2019) (1)
Complete Reference Genome Sequence of the Extensively Drug-Resistant Strain Neisseria gonorrhoeae AT159, with Ceftriaxone Resistance and High-Level Azithromycin Resistance, Using Nanopore Q20+ Chemistry and Illumina Sequencing (2022) (1)
A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae (2022) (1)
P2.019 Analytical Specificity and Sensitivity of the APTIMA Combo 2 and APTIMA GC Assays For Detection of Neisseria Gonorrhoeae on the Gen-Probe PANTHER Instrument and Verification of Specimens Positive For N. Gonorrhoeae Using Other Commercial Diagnostic NAATs (2013) (1)
Construction, immunogenicity and protective efficacy in mice of a prototype chimeric Chlamydia trachomatis MOMP vaccine candidate antigen (2011) (0)
Quality enhancements of laboratory diagnosis of sexually transmitted infections in Russia (2009) (0)
Author's response to reviews Title: HIV, STI prevalence and risk behaviours among women selling sex in Lahore, Pakistan Authors: (2010) (0)
O03.3 The european gonococcal antimicrobial surveillance programme findings 2017 (2019) (0)
A Multiplex Real-Time PCR with High Resolution Melting Analysis for the 1 Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae 2 3 (2016) (0)
Complete Reference Genome Sequence of the Clinical Neisseria gonorrhoeae Strain H035, with Resistance to the Novel Antimicrobial Zoliflodacin, Identified in Japan in 2000 (2023) (0)
P4-S1.08 Performance comparison of Neisseria gonorrhoeae (NG) sequence typing methods NG-MAST and NG-MLVA on a defined panel of isolates (2011) (0)
Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014–2016: focus on extended-spectrum cephalosporins and azithromycin (2018) (0)
P3.075 Trends in Epidemiology and Management of Reportable Sexually Transmitted Infections (STIs) in Poland (2013) (0)
Holistic actions are essential to combat the global public health burden of non-viral sexually transmitted infections: challenges and future perspectives (2014) (0)
P291 Genomic epidemiology of Neisseria gonorrhoeae isolates in Sweden – 2016 national study (2021) (0)
O13.1 Survey of antimicrobial resistance in clinical neisseria gonorrhoeae isolated over four years in nairobi – kenya (2017) (0)
P3.095 Experiences from Working with Sexually Transmitted Infections and Related Issues Among Teenagers and Youth in Tver, Russia (2013) (0)
Late-stage parenchymatous neurosyphilis presenting as general paresis of insane, Poland – case report (2016) (0)
Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, and molecular resistance (2020) (0)
Neisseria gonorrhoeae Immunotherapeutic Molecule against Fc Chimeric - A Novel Factor H (2016) (0)
Pathogenic Interplay Between Chlamydia trachomatis and Neisseria gonorrhoeae that Influences Management and Control Efforts—More Questions than Answers? (2019) (0)
O1-S03.03 Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to extended-spectrum cephalosporins in Amsterdam, the Netherlands (2011) (0)
P3.281 Gonorrhoea on the Rise in Latvia - Diagnostics and Antimicrobial Resistance Surveillance (2013) (0)
P1-S1.34 First report of the Swedish new variant of Chlamydia trachomatis (nvCT) in Russia (2011) (0)
Optimisation of treatments for oral Neisseria gonorrhoeae infection: Pharmacokinetics Study (STI-PK project) – study protocol for non-randomised clinical trial (2022) (0)
Multidrug-resistant Neisseria gonorrhoeae isolate SE690: mosaic penA-60.001 gene causing ceftriaxone resistance internationally has spread to the more antimicrobial-susceptible genomic lineage, Sweden, September 2022 (2023) (0)
P3.083 Is the Syphilis Incidence Decreasing in Georgia? (2013) (0)
01 / HIGH ANTIMICROBIAL SUSCEPTIBILITY IN NEISSERIA GONORRHOEAE ISOLATES IN THE TERNOPIL AND DNIPROPETROVSK REGIONS OF UKRAINE DURING 2013-2017 (2018) (0)
P1.11 Dampening of the mtrcde efflux pump operon in neisseria gonorrhoeae strain ho41 enhances gonococcal susceptibility to penicillin (2017) (0)
Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections. (2023) (0)
P07.10 Evaluation of the new bd max gc real time pcr assay, analytically and as a supplementary test to the bd probetec gc qx amplified dna assay, for molecular detection of neisseria gonorrhoeae (2015) (0)
P1.019 Identification of the Amino Acids Conferring High-Level Resistance to Expanded-Spectrum Cephalosporins in the penA Gene from the Neisseria Gonorrhoeae Strain H041 (2013) (0)
P3.292 The 2013 IUSTI European Collaborative Clinical Group (ECCG) Report on the Diagnosis and Management of Chlamydial Infections in Europe (2013) (0)
P141 A service evaluation for and on behalf of the European Clinical Collaborative Group (ECCG) - The management of Gonorrhoea across Europe (2016) (0)
P1.018 Analysis of Mosaic Penicillin-Binding Protein 2 Variants with Ala501 Mutations That Confer High-Level Resistance to Expanded-Spectrum Cephalosporins in Neisseria Gonorrhoeae (2013) (0)
The diagnostic-escape Finnish new variant of Chlamydia trachomatis (FI-nvCT) first described in 2019 remains present in Finland three years after the introduction of an updated aptima combo 2 assay. (2023) (0)
Defining the breakpoint for resistance to rifampicin in Neisseria meningitidis by rpoB sequencing (2009) (0)
Genetics of Chromosomally Mediated Intermediate Resistance to Ceftriaxone and Ceﬁxime in Neisseria gonorrhoeae (cid:1) (2009) (0)
Nucleotide polymorphisms in fusA associated with post-therapy fusidic acid resistance in Clostridium difficile (2011) (0)
LB1.69 Clinical and analytical evaluation of the new aptima mycoplasma genitalium assay on the panther instrument (HOLOGIC), m. genitalium prevalence, and antimicrobial resistance in m. genitalium in sweden, denmark and norway in 2016 (2017) (0)
Unencapsulated penicillin-resistant Neisseria meningitidis ST-53 clonal complex strain causing symptomatic proctitis in an HIV-negative man who has sex with men: A case report (2022) (0)
Characterization of Chlamydia trachomatis genotype E by multi locus sequence typing after the finding of the new variant (nvCt) in a Swedish county 2006 (2008) (0)
Mycoplasma genitalium prevalence, antimicrobial resistance-associated mutations, and coinfections with non-viral sexually transmitted infections in high-risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019–2021 (2023) (0)
P1.59 Genomic characterisation of urethritis-associated neisseria meningitidis (2017) (0)
A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch (2021) (0)
P3.327 Surveillance and Control of Sexually Transmitted Infections in Lithuania (2013) (0)
P1-S1.42 Russian gonococcal antimicrobial susceptibility programme (RU-GASP) - resistance levels in 2010 and trends during 2005–2010 (2011) (0)
Cost-effectiveness of testing for Mycoplasma genitalium among men who have sex with men in Australia (2022) (0)
Multicenter Study for Deﬁning the Breakpoint for Rifampin Resistance in Neisseria meningitidis by rpoB Sequencing (cid:1) (2010) (0)
P3.152 Prevalence of Neisseria Gonorrhoeae Infection in Two Distinct Men-Who-Have-Sex-With-Men (MSM) Populations in Slovenia in 2012 (2013) (0)
Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae (0)
006.2 High in vitro susceptibility to the novel spiropyrimidinetrione azd0914 among 873 contemporary clinical neisseria gonorrhoeae isolates in 21 european countries during 2012–2014 (2015) (0)
01 / OUTBREAK OF NEISSERIA GONORRHOEAE WITH DECREASED SUSCEPTIBILITY AND RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS IN CÓRDOBA CITY, ARGENTINA. (2018) (0)
Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae (2016) (0)
Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review (2023) (0)
Neisseria gonorrhoeae (2020) (0)
O06.2 In vitro combination testing and selection of resistance to zoliflodacin combined with six antimicrobials for N. gonorrhoeae (2019) (0)
Optimization of infection in murine model with Chlamydia trachomatis for vaccine studies (2013) (0)
P5.081 Analytical Evaluation of the GeneXpert ® CT/NG, the First Genetic Point of Care Assay For Simultaneous Detection of Neisseria Gonorrhoeae and Chlamydia Trachomatis (2013) (0)
P637 Neisseria gonorrhoeae genomic diversity in high risk groups in switzerland (2019) (0)
P1-S1.43 Antimicrobial susceptibility and molecular epidemiological characteristics of Neisseria gonorrhoeae in 2009–2010 in Belarus (2011) (0)
P2.062 Optimizations and Quality Assurance of the Laboratory Diagnosis and Treatment of Sexually Transmitted Infections in Belarus (2013) (0)
Sexual and reproductive health in Britain during the first year of the COVID-19 pandemic: cross-sectional population survey (Natsal-COVID-Wave 2) and national surveillance data (2023) (0)
Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study (2023) (0)
P5.067 The Way to Go Forward in Optimization of STI Management in Eastern Europe: Eastern European Network For Sexual and Reproductive Health (EE SRH) (2013) (0)
P5.087 Evaluation of the Multiplex AmpliSens HCV/HBV/HIV-FRT Real-Time PCR For Simultaneous Qualitative Detection of Hepatitis C RNA, Hepatitis B DNA and HIV RNA (2013) (0)
O11.4 Impact of screening of Mycoplasma genitalium and its macrolide resistance in men who have sex with men living in Australia (2021) (0)
O01.1 A tale of two halves; low extended-spectrum cephalosporin and high azithromycin resistance in neisseria gonorrhoeae in europe, 2015 (2017) (0)
gonorrhoeae and Chlamydia trachomatis Simultaneous Detection of Neisseria the First Genetic Point-of-Care Assay for Analytical Evaluation of GeneXpert CT/NG, (2014) (0)
Cefotaxime in Amsterdam, the Netherlands the Extended-Spectrum Cephalosporin Isolates with Decreased Susceptibility to Clonally Related Neisseria gonorrhoeae (2012) (0)
P3.270 Antimicrobial Susceptibility and Molecular Characterization of Neisseria Gonorrhoeae Strains from Slovenia 2008–2012 (2013) (0)
SCCmec and ACME in Staphylococcus epidermidis isolated from prosthetic joint infections (2011) (0)
P3-S7.10 Composition of vaginal microbiota in bacterial vaginosis patients and healthy women: basis for genetic diagnosis of bacterial vaginosis? (2011) (0)
'Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea' - Author's reply. (2020) (0)
P650 Randomized clinical trial comparing gentamicin+azithromycin vs. ceftriaxone + azithromycin for rectal and pharyngeal gonorrhea (2019) (0)
THE RESULTS OF MONITORING THE ANTIBACTERIAL RESISTANCE OF N. GONORRHOEAE IN THE MOGILEV CITY FOR 2017-2019 (2022) (0)
05 / FIRST NATIONWIDE ANTIMICROBIAL SUSCEPTIBILITY SURVEILLANCE FOR NEISSERIA GONORRHOEAE IN BRAZIL, 2015-2016 (2018) (0)
O16 Ethnic variations in sexual risk behaviour, sexual health service use and unmet need during the first year of the COVID-19 pandemic: an analysis of population-based survey and surveillance data (2022) (0)
The impact of antimicrobials on gonococcal evolution (2019) (0)
003.6 Timing of test of cure for anogenital neisseria gonorrhoeae infections - a prospective cohort study using nucleic acid amplification tests (2015) (0)
Quantitation of all Four Gardnerella vaginalis Clades Detects Abnormal Vaginal Microbiota Characteristic of Bacterial Vaginosis More Accurately than Putative G. vaginalis Sialidase A Gene Count (2019) (0)
Sequencing of the porB gene of Neisseria gonorrhoeae (Ng); sequence variability inventory and comparative alignments for cluster confirmation. (2001) (0)
Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the Oxford Nanopore MinION sequencer (2018) (0)
between Neisseria gonorrhoeae strains causing local or (2013) (0)
Diagnosis of non-viral sexually transmitted infections in Lithuania and international recommendations. (2006) (0)
P5.064 Preliminary Analytical Evaluation of Artus® CT/NG, For Simultaneous Detection of Neisseria Gonorrhoeae and Chlamydia Trachomatis (2013) (0)
Staphylococcal cassette chromosome mec (SCCmec) and arginine catabolic mobile element (ACME) in Staphylococcus epidermidis isolated from prosthetic joint infections (2013) (0)
Acid Responsive Helicobacter pylori Adherence : Implications for Chronic Infection and Disease (2016) (0)
Genetic variant (genovar) determination of Neisseria gonorrhoeae by pyrosequencing of highly polymorphic segments of the porB gene (2012) (0)
Invasive meningococcal disease in Sweden 2016 (2017) (0)
Mycoplasma genitalium antimicrobial (azithromycin and moxifloxacin) resistance and treatment outcome in Sofia, Bulgaria, 2018-2021. (2023) (0)
P2.023 Organisation of the Laboratory Services For Diagnosis of Sexually Transmitted Infections in Tver, Russia (2013) (0)
009.1 Standardised, quality assured time-kill curve analysis and pharmacodynamic functions of different antibiotics for in vitro evaluation of treatment regimens for neisseria gonorrhoeae (2015) (0)
Neisseria gonorrhoeae Change in Antibiotic Resistance Caused by a Single Base Pair A Novel Mechanism of High-Level , Broad-Spectrum 2011 (0)
, Takeshi High-Level Resistance to Ceftriaxone Characterization of the First Strain with Era of Untreatable Gonorrhea ? : Detailed Is Neisseria gonorrhoeae Initiating a Future (2011) (0)
Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute disc diffusion techniques (2016) (0)
Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines (2011) (0)
Chlamydia trachomatis in Iceland: Prevalence, Clinico-epidemiological Features and Comparison of Cobas 480 CT/NG and Aptima Combo 2 (CT/NG) for Diagnosis (2021) (0)
Mycoplasma genitalium: whole genome sequence analysis, recombination and population structure (2017) (0)
Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer (2016) (0)
Improvement in Neisseria gonorrhoeae culture rates by bedside inoculation and incubation at a clinic for sexually transmitted infections (2023) (0)
Factors associated with anitmicrobial resistant gonorrheoea infections in men who have sex with men in Switzerland: case control study (2017) (0)
P350 What is the optimum method for collecting robust data to understand a nation’s sexual health needs? (2019) (0)
Whole-genome characterization of emergent invasive Neisseria meningitidis serogroup Y in Sweden from the two recent decades (2014) (0)
P3-S1.22 Evaluation of performance of six commercial assays for detection of characterised isolates of Neisseria gonorrhoeae and other Neisseria spp. (2011) (0)
Prevalence and typing of Propionibacterium acnes in prostate tissue obtained from men with prostate cancer and from health controls (2013) (0)
A view of the Neisseria gonorrhoeae population in Sweden in 2005 : phenotypic and genetic characterisation (2006) (0)
identification of the new variant typing in a Swedish county before and after sequencing and multilocus sequence ompA by Chlamydia trachomatis Characterisation of (0)
P39 How did the COVID-19 pandemic affect unmet need for condoms at a population level? (Natsal-COVID) (2022) (0)
Antimicrobial resistance, a European perspective (2014) (0)
Sasiprapa gonorrhoeae Isolates in Bangkok , Thailand Penicillinase-Producing Neisseria Their Corresponding Molecular Analyses of TEM Genes and (2012) (0)
P2.052 Analytical Evaluation of the Specificity and Neisseria Gonorrhoeae Detection of the Novel GeneProof N. Gonorrhoeae Dual-Target PCR Assay (2013) (0)
009.2 Establishment of the gonorrhoea mouse model for pre-clinical testing of antimicrobial agents against neisseria gonorrhoeae (2015) (0)
[The incidence of gonorrhoea has dramatically increased in Sweden during the last 10 years]. (2021) (0)
C4BP-IGM FUSION PROTEIN AS A NOVEL THERAPEUTIC APPROACH TO TREAT NEISSERIA GONORRHOEAE INFECTIONS (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Magnus Unemo?

Magnus Unemo is affiliated with the following schools:

Örebro University
Uppsala University
University College London